Covid-19 fourth wave: 'Single, variant-proof' vaccine coming soon!

CEPI will fund the initiative under its USD 200 million programme to advance the development of vaccines that provide broad protection against SARS-Cov-2 variants and other betacoronaviruses.

Related Keywords

India ,Sydney ,New South Wales ,Australia ,New Delhi ,Delhi ,Bharat ,Richard Hatchett ,Krishna Ella ,Bharat Biotech International ,Coalition For Epidemic Preparedness Innovations ,University Of Sydney ,Bharat Biotech ,Epidemic Preparedness Innovations ,Switzerland Based Excellgene ,Biotech Chairman ,Managing Director Krishna Ella ,